FYN A, Active(F15-10G)

FYN A, Active(F15-10G)

  • $226.00


FOR BULK ORDER REQUESTS PLEASE CONTACT US

Description :Full-length recombinant human FYN A was expressed by baculovirus in Sf9 insect cells using an N-terminal GST tag.

Species :Human

Tag :GST tag

Expression System:Sf9 insect cells using baculovirus

Sequence :Full Length

Genbank Number :NM_002037

Specific Activity :Sample Kinase Activity Plot. For specific information on a given lot, see related technical data sheet.

Purity :Sample Purity Data. For specific information on a given lot, see related technical data sheet.

Storage, Stability and Shipping :Store product at –70oC. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.

Applications :Kinase Assay, Western Blot

Molecular Weight :~85kDa

Gene Aliases :SLK, SYN, MGC45350

Scientific Background :Fyn A (Fyn isoform A) is a member of the SRC tyrosine kinase oncogene family showing high homology to YES1, FGR and SRC. Fyn has been shown to phosphorylate Dab1, an intracellular adaptor protein that interacts with amyloid precursor protein (APP) and apoE receptor 2 (apoEr2) (1). The interaction of Fyn and Dab1 regulates the phosphorylation, trafficking, and processing of APP and apoEr2. Fyn expression has been shown to be significantly increased in Chronic Myelogenous Leukemia (CML) (2). Knockdown of Fyn with shRNA slows leukemia cell growth, inhibits clonogenicity, and leads to increased sensitivity to imatinib.

References :
1. Hoe, H S. et al: Fyn modulation of Dab1 effects on amyloid precursor protein and ApoE receptor 2 processing. J. Biol. Chem. 2008 Mar 7;283(10):6288-99.

2. Ban, K. et al: BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia. Blood, 2008 Mar 1;111(5):2904-8.

Product Sheets (By Lot #) :

V333-2.pdf

V358-1.pdf

E263-3.pdf

E036-2.pdf

Q2560-9.pdf

Research Areas :Cancer, Neurobiology, Inflammation, Cardiovascular Disease, ERK/MAPK Pathway, Invasion/Metastasis, Cytoplasmic Tyrosine Kinases, Cancer, Neurobiology, Inflammation, Cardiovascular Disease, ERK/MAPK Pathway, Invasion/Metastasis, Cytoplasmic Tyrosine Kinases